Dixestivo
Servizo
Hospital Universitario La Fe
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Fe (163)
2024
-
Baiona's Consensus Statement for Fecal Incontinence. Spanish Association of Coloproctology
Cirugia Espanola, Vol. 102, Núm. 3, pp. 158-173
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia
-
Initial Management of Intra-abdominal Abscesses and Preventive Strategies for Abscess Recurrence in Penetrating Crohn's Disease: A National, Multicentre Study Based on ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 4, pp. 578-588
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615
-
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease
Gastroenterologia y Hepatologia
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2023
-
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Gastroenterologia y Hepatologia
-
Best practices during COVID-19 pandemic in solid organ transplant programs in Spain
Transplantation Reviews, Vol. 37, Núm. 1
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management
Journal of Clinical Medicine, Vol. 12, Núm. 13
-
Inadequate social support decreases survival in decompensated liver cirrhosis patients
Gastroenterologia y Hepatologia, Vol. 46, Núm. 1, pp. 28-38
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
-
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
Scandinavian Journal of Gastroenterology
-
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162
-
SEED Consensus Document on SpyGlass-DS
Gastroenterologia y Hepatologia, Vol. 46, Núm. 1, pp. 69-79
-
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
PLoS Medicine, Vol. 20, Núm. 10
-
Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' Perspectives
Telemedicine journal and e-health : the official journal of the American Telemedicine Association, Vol. 29, Núm. 10, pp. 1504-1513